On June 6, 2018 BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, reported that the company will present at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, CA (Press release, BeiGene, JUN 6, 2018, View Source;p=RssLanding&cat=news&id=2353457 [SID1234527195]). The presentation is scheduled for 11:20 AM PST on Tuesday, June 12, 2018.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast can be accessed from the investors section of BeiGene’s website at View Source An archived replay will be available for 90 days following the event.

On June 6, 2019 Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, reported Susan M. Molineaux, Ph.D, founder, CEO and President and Keith Orford, M.D., Ph.D., Senior Vice President of Clinical Development will participate in the following two investment conferences in June (Press release, Calithera Biosciences, JUN 6, 2018, View Source [SID1234535238]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Jefferies 2018 Healthcare Conference at the Grand Hyatt in New York City. Calithera will present at the conference today, June 6, 2018 at 8:00 a.m. Eastern time. A live webcast of this presentation will be accessible via the media and investors page of www.calithera.com. An archived replay of the webcast will be available on the Company’s website for 30 days following the conference.

The JMP Securities 2018 Life Sciences Conference at the St.Regis in New York City. Calithera will participate in a panel discussion on June 20, 2018 at 3:30 p.m. Eastern time.

On June 6, 2018 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) reported that management will present at the Jefferies 2018 Global Healthcare Conference in New York, NY on Friday, June 8, 2018 at 10:30 AM ET and host one-on-one meetings (Press release, CTI BioPharma, JUN 6, 2018, View Source;p=RssLanding&cat=news&id=2353463 [SID1234527196]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma’s website at www.ctibiopharma.com.

On June 5, 2018 Jounce Therapeutics, Inc. (the "Company") conducted meetings with investors attending the 2018 American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) Annual Meeting in Chicago, Illinois (Presentation, Jounce Therapeutics, JUN 5, 2018, View Source [SID1234527180]). As part of these meetings, the Company delivered the slide presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On June 5, 2018 LabCorp (NYSE: LH) reported it will participate at the 38th Annual William Blair Growth Stock Conference (Press release, LabCorp, JUN 5, 2018, View Source;p=RssLanding&cat=news&id=2353390 [SID1234527182]). LabCorp’s presentation is planned for Tuesday, June 12, 2018 at 12:10 PM (CT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be available via the Company website at www.labcorp.com and archived for replay.